BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33248066)

  • 1. Mean and visit-to-visit variability of glycemia and left ventricular diastolic dysfunction: A longitudinal analysis of 3025 adults with serial echocardiography.
    Ahn J; Koh J; Kim D; Kim G; Hur KY; Seo SW; Kim K; Kim JH; Yang JH; Jin SM
    Metabolism; 2021 Mar; 116():154451. PubMed ID: 33248066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visit-to-visit fasting plasma glucose variability is an important risk factor for long-term changes in left cardiac structure and function in patients with type 2 diabetes.
    Tang X; Zhong J; Zhang H; Luo Y; Liu X; Peng L; Zhang Y; Qian X; Jiang B; Liu J; Li S; Chen Y
    Cardiovasc Diabetol; 2019 Apr; 18(1):50. PubMed ID: 30992008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.
    Chiu HT; Li TC; Li CI; Liu CS; Lin WY; Lin CC
    PLoS One; 2017; 12(5):e0177184. PubMed ID: 28489885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study.
    Dinh W; Lankisch M; Nickl W; Scheyer D; Scheffold T; Kramer F; Krahn T; Klein RM; Barroso MC; Füth R
    Cardiovasc Diabetol; 2010 Oct; 9():63. PubMed ID: 20950415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI.
    Yang CD; Shen Y; Ding FH; Yang ZK; Hu J; Shen WF; Zhang RY; Lu L; Wang XQ
    Cardiovasc Diabetol; 2020 Sep; 19(1):131. PubMed ID: 32878604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Visit-to-Visit Fasting Plasma Glucose Variability on the Development of Type 2 Diabetes: A Nationwide Population-Based Cohort Study.
    Kim JA; Lee JS; Chung HS; Roh E; Lee YB; Hong SH; Kim NH; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi KM
    Diabetes Care; 2018 Dec; 41(12):2610-2616. PubMed ID: 30254081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction.
    Chew GT; Watts GF; Davis TM; Stuckey BG; Beilin LJ; Thompson PL; Burke V; Currie PJ
    Diabetes Care; 2008 Aug; 31(8):1502-9. PubMed ID: 18487480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mean and Variability of Lipid Measurements and Risk for Development of Subclinical Left Ventricular Diastolic Dysfunction.
    Park J; Kang M; Ahn J; Kim MY; Choi MS; Lee YB; Kim G; Hur KY; Kim JH; Yang JH; Jin SM
    Diabetes Metab J; 2022 Mar; 46(2):286-296. PubMed ID: 34802217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community.
    Liang D; Shi G; Xu M; Yin J; Liu Y; Yang J; Xu L
    J Diabetes Investig; 2024 May; 15(5):608-613. PubMed ID: 38363189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated hemoglobin vs fasting plasma glucose as a predictor of left ventricular dysfunction after ST-elevation myocardial infarction.
    Tsai JP; Tian J; Wang WY; Ng AC
    Can J Cardiol; 2015 Jan; 31(1):44-9. PubMed ID: 25547549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired fasting glucose and left ventricular diastolic dysfunction in middle-age adults: a retrospective cross-sectional analysis of 2971 subjects.
    Milwidsky A; Maor E; Kivity S; Berkovitch A; Zekry SB; Tenenbaum A; Fisman EZ; Erez A; Segev S; Sidi Y; Goldenberg I; Kuperstein R
    Cardiovasc Diabetol; 2015 Sep; 14():119. PubMed ID: 26369690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes.
    Mantovani A; Pernigo M; Bergamini C; Bonapace S; Lipari P; Pichiri I; Bertolini L; Valbusa F; Barbieri E; Zoppini G; Bonora E; Targher G
    PLoS One; 2015; 10(8):e0135329. PubMed ID: 26252899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Long-term HbA
    Sheng CS; Tian J; Miao Y; Cheng Y; Yang Y; Reaven PD; Bloomgarden ZT; Ning G
    Diabetes Care; 2020 Jun; 43(6):1185-1190. PubMed ID: 32229597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of Uncontrolled Metabolic Risk Factors and Left Ventricular Structure and Function in Patients With Type 2 Diabetes Mellitus.
    Jørgensen PG; Jensen MT; Biering-Sørensen T; Mogelvang R; Fritz-Hansen T; Vilsbøll T; Rossing P; Jensen JS
    J Am Heart Assoc; 2018 Oct; 7(19):e008856. PubMed ID: 30371320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mean and visit-to-visit variability of glycated hemoglobin, and the risk of non-alcoholic fatty liver disease.
    Yoo JH; Kang M; Kim G; Hur KY; Kim JH; Sinn DH; Jin SM
    J Diabetes Investig; 2021 Jul; 12(7):1252-1262. PubMed ID: 33135331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function.
    Zoppini G; Bergamini C; Bonapace S; Rossi A; Trombetta M; Mantovani A; Toffalini A; Lanzoni L; Bertolini L; Zenari L; Bonora E; Targher G
    J Diabetes Complications; 2017 Jun; 31(6):1035-1040. PubMed ID: 28258906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides.
    Romano S; Di Mauro M; Fratini S; Guarracini L; Guarracini F; Poccia G; Penco M
    Cardiovasc Diabetol; 2010 Dec; 9():89. PubMed ID: 21162718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visit-to-Visit Variations in Fasting Plasma Glucose and HbA
    Li TC; Yang CP; Tseng ST; Li CI; Liu CS; Lin WY; Hwang KL; Yang SY; Chiang JH; Lin CC
    Diabetes Care; 2017 Sep; 40(9):1210-1217. PubMed ID: 28705834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.